{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:22:23Z","timestamp":1766514143986,"version":"3.44.0"},"reference-count":19,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,1,5]]},"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p>Drug-induced cholestasis has a wide range of clinical presentations, and in a small number of patients, it can progress to severe ductopenia. A 63-year-old woman was referred to our department with progressive cholestasis and hyperbilirubinaemia following a course of flucloxacillin. Despite the comprehensive laboratory, imaging and genetic investigations, no other cause for the cholestasis was demonstrated. Sequential liver biopsies confirmed the development of vanishing bile duct syndrome. She developed significant cachexia and pruritus that did not respond to medical therapy, and hence she was listed for liver transplantation. She underwent liver transplantation 6 months after the initial drug-induced injury. She has remained well with good graft function at 1-year follow-up. The case highlights an extreme form of drug-induced ductopenia and underscores the need for meticulous hepatology input and consideration of liver transplantation in some patients.<\/jats:p>","DOI":"10.1136\/bcr-2019-233052","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T04:36:14Z","timestamp":1579149374000},"page":"e233052","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Successful liver transplantation for drug-induced vanishing bile duct syndrome"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2975-5197","authenticated-orcid":false,"given":"Ahmed","family":"Hashim","sequence":"first","affiliation":[{"name":"Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Barnabas","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Miquel","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosh","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,1,15]]},"reference":[{"key":"2025082804080730000_13.1.e233052.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2007.11.007"},{"key":"2025082804080730000_13.1.e233052.2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3748\/wjg.v23.i2.366","article-title":"Vanishing bile duct syndrome in Hodgkin\u2019s lymphoma: A case report and literature review","volume":"23","author":"Bakhit","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2025082804080730000_13.1.e233052.3","doi-asserted-by":"crossref","unstructured":"Dancygier H . Biliary ductopenia (vanishing bile duct syndrome). in: clinical hepatology. Berlin, Heidelberg: Springer, 2010.","DOI":"10.1007\/978-3-642-04519-6_22"},{"key":"2025082804080730000_13.1.e233052.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03717.x"},{"key":"2025082804080730000_13.1.e233052.5","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.12849","article-title":"Hepatology: rare Stevens-Johnson syndrome and vanishing bile duct syndrome induced by acetaminophen, requiring liver transplantation","volume":"30","author":"Harimoto","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"2025082804080730000_13.1.e233052.6","doi-asserted-by":"publisher","DOI":"10.4065\/73.3.285"},{"key":"2025082804080730000_13.1.e233052.7","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.kjms.2013.05.002","article-title":"Hodgkin's lymphoma-related vanishing bile duct syndrome: a case report and literature review","volume":"29","author":"Wong","year":"2013","journal-title":"Kaohsiung J Med Sci"},{"key":"2025082804080730000_13.1.e233052.8","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000196406.15110.60"},{"key":"2025082804080730000_13.1.e233052.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80476-3"},{"key":"2025082804080730000_13.1.e233052.10","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpg.0000178086.44155.73"},{"key":"2025082804080730000_13.1.e233052.11","doi-asserted-by":"crossref","first-page":"701","DOI":"10.5694\/j.1326-5377.1989.tb139652.x","article-title":"Prolonged hepatic cholestasis after flucloxacillin therapy","volume":"151","author":"Turner","year":"1989","journal-title":"Med J Aust"},{"key":"2025082804080730000_13.1.e233052.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703203361204"},{"key":"2025082804080730000_13.1.e233052.13","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/hep.28967","article-title":"Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements","volume":"65","author":"Bonkovsky","year":"2017","journal-title":"Hepatology"},{"key":"2025082804080730000_13.1.e233052.14","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.4697"},{"key":"2025082804080730000_13.1.e233052.15","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/MPG.0b013e3182a95951","article-title":"Nonsteroidal anti-inflammatory drug-induced vanishing bile duct syndrome treated with plasmapheresis","volume":"57","author":"Kawasaki","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025082804080730000_13.1.e233052.16","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-2239"},{"key":"2025082804080730000_13.1.e233052.17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/295891","article-title":"Management of pruritus in chronic liver disease","volume":"2015","author":"Bhalerao","year":"2015","journal-title":"Dermatol Res Pract"},{"key":"2025082804080730000_13.1.e233052.18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jpainsymman.2011.11.007","article-title":"The role of ondansetron in the management of cholestatic or uremic pruritus--a systematic review.","volume":"44","author":"To","year":"2012","journal-title":"J Pain Symptom Manage"},{"key":"2025082804080730000_13.1.e233052.19","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1023\/A:1010679502324","article-title":"Idiopathic adulthood ductopenia: long-term follow-up after liver transplantation","volume":"46","author":"Rios","year":"2001","journal-title":"Dig Dis Sci"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-233052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T11:08:16Z","timestamp":1756379296000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-233052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,15]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1136\/bcr-2019-233052"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-233052","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}